BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 21797795)

  • 1. Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.
    Ishimitsu T; Ohno E; Nakano N; Furukata S; Akashiba A; Minami J; Numabe A; Matsuoka H
    Clin Exp Hypertens; 2011; 33(6):366-72. PubMed ID: 21797795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
    Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year.
    Sato N; Saijo Y; Sasagawa Y; Morimoto H; Takeuchi T; Sano H; Koyama S; Takehara N; Morita K; Sumitomo K; Maruyama J; Kikuchi K; Hasebe N;
    J Hypertens; 2013 Jun; 31(6):1245-55. PubMed ID: 23492647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of losartan/hydrochlorothiazide on serum uric acid levels and blood pressure in hypertensive patients.
    Fujimori S; Oka Y; Ogata N; Eto K
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1030-4. PubMed ID: 22132952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study.
    Toh R; Ishida T; Nishimura K; Nonaka H; Inoue Y; Kitagawa Y; Suematsu M; Miki T; Emoto N; Hirata K
    Hypertens Res; 2012 Nov; 35(11):1080-6. PubMed ID: 22786569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive treatment using an angiotensin receptor blocker and a thiazide diuretic improves patients' quality of life: the Saga Challenge Antihypertensive Study (S-CATS).
    Kamura A; Inoue T; Kuroki S; Ishida S; Iimori K; Kato T; Naitoh H; Tamesue S; Ikeda H; Node K
    Hypertens Res; 2011 Dec; 34(12):1288-94. PubMed ID: 21814213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effect of combination therapy with an angiotensin II receptor blocker and either a low-dose diuretic or calcium channel blocker on cardiac hypertrophy in patients with hypertension.
    Okura T; Miyoshi K; Irita J; Enomoto D; Jotoku M; Nagao T; Watanabe K; Matsuoka H; Ashihara T; Higaki J;
    Clin Exp Hypertens; 2013; 35(8):563-9. PubMed ID: 23402476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
    Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
    Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
    Takenaka T; Uchida K; Kojima E; Gen S; Nodaira Y; Hoshi H; Kato N; Takane H; Ohno Y; Suzuki H
    Clin Exp Hypertens; 2011; 33(4):210-5. PubMed ID: 21699446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
    Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
    J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance.
    Hasegawa H; Kanozawa K; Asakura J; Takayanagi K; Komuro O; Fukada H; Tokushima H; Kogure H; Matsuzawa M; Mitarai T
    Hypertens Res; 2013 Sep; 36(9):776-82. PubMed ID: 23615283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.